Loading clinical trials...

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women | Clinical Trials | Clareo Health

COMPLETEDNA

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Evaluation of Texting Intervention to Improve Adherence to Antiretroviral Therapy (ART) in Young Women Infected With Human Immunodeficiency Virus (HIV)

NCT02301507•The University of Texas Health Science Center, Houston

View on ClinicalTrials.gov

Summary

There has been increasing use of technology in delivery of healthcare and increasing use of cellular phone and text messaging services to help with various healthcare related issues including but not limited to medication adherence and clinic attendance. Mobile phones technology has been used for healthcare delivery and prevention strategies such as smoking cessation. In the present era, cell phones have become part of daily life for most people even among those in lower economic groups. There have also been several studies looking at cell phone text messaging services to improve adherence to ART among HIV infected subjects but no studies have so far been done in HIV infected young women to help retention and adherence to care. The overall goal of this study is to evaluation of the impact of texting intervention to improve adherence to care and treatment in HIV infected young women. Study Hypothesis: Text message intervention will improve adherence to ART in HIV infected young women.

Eligibility

Age

18 - 40 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. HIV-infected women who have been newly diagnosed within the past 1 year or who are just entering into care at Thomas Street Health Center.
•2. Subjects must be 18 years or older.
•3. Subjects must have cell phones with texting capability.
•4. Ability to speak, read, or understand English or Spanish.
•5. Must be willing and able to respond to text messages.

Exclusion Criteria

•1\. Women who are unable to speak, read, or understand English or Spanish

Locations (1)

Thomas Street Health Center

Houston, Texas, United States

Key Dates

Start Date

November 1, 2014

Primary Completion Date

August 1, 2015

Completion Date

July 1, 2016

Last Updated

May 23, 2017

Enrollment

ACTUAL participants

Conditions

HIV Infection

Interventions

cell phone SMS text messaging

BEHAVIORAL

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

RECRUITING

Skeletal Muscle Energetics and Fatiguability in Older Individuals

NCT04142047

HIVHIV Infections

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 23, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Inclusion Criteria

Exclusion Criteria

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Skeletal Muscle Energetics and Fatiguability in Older Individuals

A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR)

Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706